TFF PHARMACEUTICALS, INC. Proceeds from Issuance Initial Public Offering
TFF PHARMACEUTICALS, INC. reported Proceeds from Issuance Initial Public Offering of $903.55 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2024-11-20
- TFF PHARMACEUTICALS, INC. proceeds from issuance initial public offering for the quarter ending 2024-03-31 was $903.55K.
- TFF PHARMACEUTICALS, INC. proceeds from issuance initial public offering for the quarter ending 2023-12-31 was $0.00.
- TFF PHARMACEUTICALS, INC. proceeds from issuance initial public offering for fiscal 2023 was $5.06M.
| Period end | Proceeds from Issuance Initial Public Offering 0 month | Proceeds from Issuance Initial Public Offering 3 month | Proceeds from Issuance Initial Public Offering 6 month | Proceeds from Issuance Initial Public Offering 9 month | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $903.55K 10-Q · filed 2024-05-14 | $903.55K derived: sum of 2 quarters · filed 2024-05-14 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.06M 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $5.06M 10-Q · filed 2024-11-20 | ||||
| 2022-06-10 | $35.00M 10-Q · filed 2023-11-14 |